Caffeic acid phenethyl ester induces apoptosis of human pancreatic cancer cells involving caspase and mitochondrial dysfunction

Pancreatology

Volumn 8, Issue 6, 2008, Pages 566-576

  Chen, Ming Jen ^a   Chang, Wen Hsiung ^a   Lin, Ching Chung ^a   Liu, Chia Yuan ^a   Wang, Tsang En ^a   Chu, Cheng Hsin ^a   Shih, Shou Chuan ^a   Chen, Yu Jen ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; BxPC 3 cells; Caffeic acid phenethyl ester; Caspase; Mitochondrial dysfunction; Pancreatic cancer

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CAFFEIC ACID PHENETHYL ESTER; CASPASE 3; CASPASE 7; GEMCITABINE; LIPOCORTIN 5;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVITY; ENZYME ASSAY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRION; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 52549092973     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000159843     Document Type: Article

References (40)

1. Schneider G, Siveke JT, Eckel F, Schmid RM: Pancreatic cancer: basic and clinical aspects. Gastroenterology 2005;128:1606-1625.
2. Freelove R, Walling AD: Pancreatic cancer: diagnosis and management. Am Fam Physician 2006;73:485-492.
3. Lygidakis NJ, Jain S, Sacchi M, Vrachnos P: Adenocarcinoma of the pancreas: past, present and future. Hepatogastroenterology 2005;52:1281-1292.
4. Singh M, Maitra A: Precursor lesions of pancreatic cancer: molecular pathology and clinical implications. Pancreatology 2007;7:9-19.
5. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ: Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-130.
6. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997;15:2403-2413.
7. Abbruzzese JL: New applications of gemcitabine and future directions in the management of pancreatic cancer. Cancer 2002;95:941-945.
8. Kindler HL: Front-line therapy of advanced pancreatic cancer. Semin Oncol 2005;32:S33-S36.
9. Lockhart AC, Rothenberg ML, Berlin JD: Treatment for pancreatic cancer: current therapy and continued progress. Gastroenterology 2005;128:1642-1654.
10. Kopper L, Zalatnai A, Timar J: Genomics of pancreatic cancer: does it make any improvement in diagnosis, prognosis and therapy? Pathol Oncol Res 2005;11:69-73.
11. Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, Goodman SN, Sohn TA, Hruban RH, Yeo CJ, Kern SE: Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res 1997;57:1731-1734.
12. Hruban RH, van Mansfeld AD, Offerhaus GJ, van Weering DH, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL: K-ras oncogene activation in adenocarcinoma of the human pancreas: a study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993;143:545-554.
13. Douziech N, Calvo E, Laine J, Morisset J: Activation of MAP kinases in growth responsive pancreatic cancer cells. Cell Signal 1999;11:591-602.
14. Perugini RA, McDade TP, Vittimberga FJ Jr, Callery MP: Pancreatic cancer cell proliferation is phosphatidylinositol 3-kinase dependent. J Surg Res 2000;90:39-44.
15. Wang W, Abbruzzese JL, Evans DB, Callery MP: The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 1999;5:119-127.
16. Westphal S, Kalthoff H: Apoptosis: targets in pancreatic cancer. Mol Cancer 2003;2:6.
17. Gilliam AD, Watson SA: Emerging biological therapies for pancreatic carcinoma. Eur J Surg Oncol 2002;28:370-378.
18. Yokoi K, Sasaki T, Bucana CD, Fan D, Baker CH, Kitadai Y, Kuwai T, Abbruzzese JL, Fidler IJ: Simultaneous inhibition of EGFR, VEGFR, and platelet-derived growth factor receptor signaling combined with gemcitabine produces therapy of human pancreatic carcinoma and prolongs survival in an orthotopic nude mouse model. Cancer Res 2005;65:10371-10380.
19. Baker CH, Solorzano CC, Fidler IJ: Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer. Cancer Res 2002;62:1996-2003.
20. Son S, Lewis BA: Free radical scavenging and antioxidative activity of caffeic acid amide and ester analogues: structure-activity relationship. J Agric Food Chem 2002;50:468-472.
21. Wei X, Zhao L, Ma Z, Holtzman DM, Yan C, Dodel RC, Hampel H, Oertel W, Farlow MR, Du Y: Caffeic acid phenethyl ester prevents neonatal hypoxic-ischaemic brain injury. Brain 2004;127:2629-2635.
22. Ozyurt H, Irmak MK, Akyol O, Sogut S: Caffeic acid phenethyl ester changes the indices of oxidative stress in serum of rats with renal ischaemia-reperfusion injury. Cell Biochem Funct 2001;19:259-263.
23. Michaluart P, Masferrer JL, Carothers AM, Subbaramaiah K, Zweifel BS, Koboldt C, Mestre JR, Grunberger D, Sacks PG, Tanabe T, Dannenberg AJ: Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res 1999;59:2347-2352.
24. Natarajan K, Singh S, Burke TR Jr, Grunberger D, Aggarwal BB: Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci USA 1996;93:9090-9095.
25. Mahmoud NN, Carothers AM, Grunberger D, Bilinski RT, Churchill MR, Martucci C, Newmark HL, Bertagnolli MM: Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 2000;21:921-927.
26. Chen YJ, Shiao MS, Wang SY: The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells. Anticancer Drugs 2001;12:143-149.
27. Chen YJ, Shiao MS, Hsu ML, Tsai TH, Wand SY: Effect of caffeic acid phenethyl ester, an antioxidant from propolis, on inducing apoptosis in human leukemic HL-60 cells. J Agric Food Chem 2001;49:5615-5619.
28. Watabe M, Hishikawa K, Takayanagi A, Shimizu N, Nakaki T: Caffeic acid phenethyl ester induces apoptosis by inhibition of NFkappaB and activation of Fas in human breast cancer MCF-7 cells. J Biol Chem 2004;279:6017-6026.
29. Liao HF, Chen YY, Liu JJ, Hsu ML, Shieh HJ, Liao HJ, Shieh CJ, Shiao MS, Chen YJ: Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. J Agric Food Chem 2003;51:7907-7912.
30. Chen MF, Wu CT, Chen YJ, Keng PC, Chen WC: Cell killing and radiosensitization by caffeic acid phenethyl ester (CAPE) in lung cancer cells. J Radiat Res (Tokyo) 2004;45:253-260.
31. Lee YJ, Liao PH, Chen WK, Yang CY: Preferential cytotoxicity of caffeic acid phenethyl ester analogues on oral cancer cells. Cancer Lett 2000;153:51-56.
32. Chen YJ, Liao HF, Tsai TH, Wang SY, Shiao MS: Caffeic acid phenethyl ester preferentially sensitizes CT26 colorectal adenocarcinoma to ionizing radiation without affecting bone marrow radioresponse. Int J Radiat Oncol Biol Phys 2005;63:1252-1261.
33. Pellegata NS, Sessa F, Renault B, Bonato M, Leone BE, Solcia E, Ranzani GN: K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 1994;54:1556-1560.
34. Giehl K, Skripczynski B, Mansard A, Menke A, Gierschik P: Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration. Oncogene 2000;19:2930-2942.
35. Akada M, Crnogorac-Jurcevic T, Lattimore S, Mahon P, Lopes R, Sunamura M, Matsuno S, Lemoine NR: Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer. Clin Cancer Res 2005;11:3094-3101.
36. Chen WB, Lenschow W, Tiede K, Fischer JW, Kalthoff H, Ungefroren H: Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells. J Biol Chem 2002;277:36118-36128.
37. Bergman AM, Pinedo HM, Talianidis I, Veerman G, Loves WJ, van der Wilt CL, Peters GJ: Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines. Br J Cancer 2003;88:1963-1970.
38. Gukovskaya AS, Pandol SJ: Cell death pathways in pancreatitis and pancreatic cancer. Pancreatology 2004;4:567-586.
39. Sutton R, Criddle D, Raraty MG, Tepikin A, Neoptolemos JP, Petersen OH: Signal transduction, calcium and acute pancreatitis. Pancreatology 2003;3:497-505.
40. Ricci MS, Zong WX: Chemotherapeutic approaches for targeting cell death pathways: chemotherapeutic approaches for targeting cell death pathways. Oncologist 2006;11:342-357.